Terms: = Adult Hodgkin lymphoma AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Treatment
498 results:
1. hodgkin lymphoma: hypodense lesions in mediastinal masses.
Damek A; Kurch L; Franke FC; Attarbaschi A; Beishuizen A; Cepelova M; Ceppi F; Daw S; Dieckmann K; Fernández-Teijeiro A; Feuchtinger T; Flerlage JE; Fosså A; Georgi TW; Hasenclever D; Hraskova A; Karlen J; Klekawka T; Kluge R; Körholz D; Landman-Parker J; Leblanc T; Mauz-Körholz C; Metzler M; Pears J; Steglich J; Uyttebroeck A; Vordermark D; Wallace WH; Wohlgemuth WA; Stoevesandt D
Sci Rep; 2024 Jun; 14(1):14591. PubMed ID: 38918503
[TBL] [Abstract] [Full Text] [Related]
2. Comparing symptom clusters in cancer survivors by cancer diagnosis: A latent class profile analysis.
Lee LJ; Han CJ; Saligan L; Wallen GR
Support Care Cancer; 2024 Apr; 32(5):308. PubMed ID: 38662054
[TBL] [Abstract] [Full Text] [Related]
3. Update on FDG-PET in pediatric lymphoma.
Kurch L; Kluge R
Q J Nucl Med Mol Imaging; 2024 Mar; 68(1):58-69. PubMed ID: 38587361
[TBL] [Abstract] [Full Text] [Related]
4. treatment outcomes and prognostic factors of patients with lymphoblastic lymphoma in East Asia.
Kim J; Byun JM; Hong J; Koh Y; Shin DY; Kim TM; Yoon SS; Park H; Kim I
Medicine (Baltimore); 2024 Feb; 103(7):e37100. PubMed ID: 38363899
[TBL] [Abstract] [Full Text] [Related]
5. The role of chimeric antigen receptor T cells targeting more than one antigen in the treatment of B-cell malignancies.
Brillembourg H; Martínez-Cibrián N; Bachiller M; Alserawan L; Ortiz-Maldonado V; Guedan S; Delgado J
Br J Haematol; 2024 May; 204(5):1649-1659. PubMed ID: 38362778
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic value of baseline and interim [
Yadgarov MY; Dunaykin MM; Shestopalov GI; Kailash C; Kireeva ED; Myakova NV; Likar YN
Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):1955-1964. PubMed ID: 38351389
[TBL] [Abstract] [Full Text] [Related]
7. Optimal dosage of rituximab for children with Burkitt lymphoma.
Huang S; Jin L; Yang J; Zhang M; Zhang Y; Peng Y; Duan Y; Zheng H
Ann Hematol; 2024 Mar; 103(3):893-903. PubMed ID: 38091052
[TBL] [Abstract] [Full Text] [Related]
8. [Novel CD19-KIRS2/Dap12-BB CAR-T treatment for 3 Patients with Relapsed and Refractory B-Cell Tumors].
Ji SW; Hua T; Wang JJ; Shao LY; Chen ZH; Liu JY; Cheng H; Chen W; Sun C; Wang X; Xu KL; Cao J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1860-1865. PubMed ID: 38071073
[TBL] [Abstract] [Full Text] [Related]
9. [Characteristics and impact factors of SARS-CoV-2 infection in adult patients with relapsed/refractory B-cell non-hodgkin lymphoma receiving chimeric antigen receptor T-cell therapy].
Ge T; Liu H; Wang ZH; Cao Y; Zhang YC; Huang L; Qian WB; Zhou XX
Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):825-831. PubMed ID: 38049334
[No Abstract] [Full Text] [Related]
10. Health Care Resource Utilization and Total Costs of Care for adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia in the United States: A Retrospective Claims Analysis.
Ito D; Feng C; Fu C; Kim C; Wu J; Dalton D; Epstein J; Snider JT; DuVall AS
Clin Ther; 2024 Jan; 46(1):3-11. PubMed ID: 37981560
[TBL] [Abstract] [Full Text] [Related]
11. Bortezomib Is Effective in the treatment of T Lymphoblastic Leukaemia by Inducing DNA Damage, WEE1 Downregulation, and Mitotic Catastrophe.
Din RU; Jiao A; Qiu Y; Mohan AAM; Yuen KC; Wong HT; Wan TM; Wong PO; Sin CF
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834095
[TBL] [Abstract] [Full Text] [Related]
12. Metabolic/endocrine disorders in survivors of childhood-onset and cranial radiotherapy- treated ALL/NHL: a meta-analysis.
Zhang D; Gu M
Reprod Biol Endocrinol; 2023 Oct; 21(1):91. PubMed ID: 37794442
[TBL] [Abstract] [Full Text] [Related]
13. Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma.
Yang X; Luo C; Qian J; Huang X; Zhang J; Wang J; Luo C; Qin X; Li B; Chen J
Front Immunol; 2023; 14():1219872. PubMed ID: 37736096
[TBL] [Abstract] [Full Text] [Related]
14. Testicular dysfunction at diagnosis in children and teenagers with haematopoietic malignancies improves after initial chemotherapy.
Lopez Dacal J; Prada S; Correa Brito L; Ropelato MG; Ballerini MG; Rodriguez ME; Gutiérrez ME; Soria M; Morán L; Ferraro C; Bedecarrás P; Drelichman G; Aversa L; Bergadá I; Rey RA; Grinspon RP
Front Endocrinol (Lausanne); 2023; 14():1135467. PubMed ID: 37260445
[TBL] [Abstract] [Full Text] [Related]
15. Late-onset Cognitive Impairment and Modifiable Risk Factors in adult Childhood Cancer Survivors.
Phillips NS; Stratton KL; Williams AM; Ahles T; Ness KK; Cohen HJ; Edelstein K; Yasui Y; Oeffinger K; Chow EJ; Howell RM; Robison LL; Armstrong GT; Leisenring WM; Krull KR
JAMA Netw Open; 2023 May; 6(5):e2316077. PubMed ID: 37256617
[TBL] [Abstract] [Full Text] [Related]
16. Thrombotic Events Are Unusual Toxicities of Chimeric Antigen Receptor T-Cell Therapies.
Schorr C; Forindez J; Espinoza-Gutarra M; Mehta R; Grover N; Perna F
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176053
[TBL] [Abstract] [Full Text] [Related]
17. PD-L1 expression predicts efficacy in the phase II SPiReL trial with MVP-S, pembrolizumab, and low-dose CPA in R/R DLBCL.
Amitai I; Roos K; Rashedi I; Jiang Y; Mangoff K; Klein G; Forward N; Stewart D; Laneuville P; Bence-Bruckler I; Mangel J; Tomlinson G; Berinstein NL
Eur J Haematol; 2023 Aug; 111(2):191-200. PubMed ID: 37157906
[TBL] [Abstract] [Full Text] [Related]
18. [Strategy of the French Society of Childhood Cancer (SFCE) for pediatric nodular lymphocyte predominant lymphoma].
Dourthe ME; Simonin M; Rigaud C; Haouy S; Montravers F; Ducou Le Pointe H; Garnier N; Minard-Colin V; Jo Molina T; Boudjemaa S; Leblanc T; Landman-Parker J
Bull Cancer; 2023 Sep; 110(9):968-977. PubMed ID: 37062647
[TBL] [Abstract] [Full Text] [Related]
19. Cumulative burden of 144 conditions, critical care hospitalisation and premature mortality across 26 adult cancers.
Chang WH; Neal RD; Forster MD; Lai AG
Nat Commun; 2023 Mar; 14(1):1484. PubMed ID: 36932095
[TBL] [Abstract] [Full Text] [Related]
20. Temporal evolution and differential patterns of cellular reconstitution after therapy for childhood cancers.
Hofmann G; Zierk J; Sobik B; Wotschofsky Z; Sembill S; Krumbholz M; Metzler M; Karow A
Sci Rep; 2023 Mar; 13(1):4022. PubMed ID: 36899075
[TBL] [Abstract] [Full Text] [Related]
[Next]
